These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 22882485

  • 1. Receptor tyrosine kinase inhibitors: molecularly targeted drugs for veterinary cancer therapy.
    Bavcar S, Argyle DJ.
    Vet Comp Oncol; 2012 Sep; 10(3):163-73. PubMed ID: 22882485
    [Abstract] [Full Text] [Related]

  • 2. New paradigms in anticancer therapy: targeting multiple signaling pathways with kinase inhibitors.
    Faivre S, Djelloul S, Raymond E.
    Semin Oncol; 2006 Aug; 33(4):407-20. PubMed ID: 16890796
    [Abstract] [Full Text] [Related]

  • 3. Sunitinib malate and multiple receptor tyrosine kinases inhibitors: are they also novel drugs for chronic and neurophatic pain?
    Di Lorenzo L.
    J Clin Oncol; 2007 Jul 01; 25(19):2858-9; author reply 2859-61. PubMed ID: 17602094
    [No Abstract] [Full Text] [Related]

  • 4. Phase I dose-escalating study of SU11654, a small molecule receptor tyrosine kinase inhibitor, in dogs with spontaneous malignancies.
    London CA, Hannah AL, Zadovoskaya R, Chien MB, Kollias-Baker C, Rosenberg M, Downing S, Post G, Boucher J, Shenoy N, Mendel DB, McMahon G, Cherrington JM.
    Clin Cancer Res; 2003 Jul 01; 9(7):2755-68. PubMed ID: 12855656
    [Abstract] [Full Text] [Related]

  • 5. Kinases as targets in the treatment of solid tumors.
    Giamas G, Man YL, Hirner H, Bischof J, Kramer K, Khan K, Ahmed SS, Stebbing J, Knippschild U.
    Cell Signal; 2010 Jul 01; 22(7):984-1002. PubMed ID: 20096351
    [Abstract] [Full Text] [Related]

  • 6. [Lung cancer: molecular targeting therapy].
    Kobayashi K.
    Nihon Kokyuki Gakkai Zasshi; 2004 May 01; 42(5):371-7. PubMed ID: 15168452
    [No Abstract] [Full Text] [Related]

  • 7. Lab reports and cat scans: can veterinary oncology guide our way to new treatments for human cancers?
    Airley R.
    Future Med Chem; 2012 Jul 01; 4(11):1391-4. PubMed ID: 22857529
    [No Abstract] [Full Text] [Related]

  • 8. Small molecule inhibitors in veterinary oncology practice.
    London CA.
    Vet Clin North Am Small Anim Pract; 2014 Sep 01; 44(5):893-908. PubMed ID: 25174906
    [Abstract] [Full Text] [Related]

  • 9. Focal adhesion kinase: a potential target in cancer therapy.
    van Nimwegen MJ, van de Water B.
    Biochem Pharmacol; 2007 Mar 01; 73(5):597-609. PubMed ID: 16997283
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Development of SU5416, a selective small molecule inhibitor of VEGF receptor tyrosine kinase activity, as an anti-angiogenesis agent.
    Mendel DB, Laird AD, Smolich BD, Blake RA, Liang C, Hannah AL, Shaheen RM, Ellis LM, Weitman S, Shawver LK, Cherrington JM.
    Anticancer Drug Des; 2000 Feb 01; 15(1):29-41. PubMed ID: 10888034
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. SU6668 inhibits Flk-1/KDR and PDGFRbeta in vivo, resulting in rapid apoptosis of tumor vasculature and tumor regression in mice.
    Laird AD, Christensen JG, Li G, Carver J, Smith K, Xin X, Moss KG, Louie SG, Mendel DB, Cherrington JM.
    FASEB J; 2002 May 01; 16(7):681-90. PubMed ID: 11978732
    [Abstract] [Full Text] [Related]

  • 15. [Tyrosine kinase receptor-ras-ERK signal transduction pathway as therapeutic tarfet in cancer].
    Leirdal M, Sioud M.
    Tidsskr Nor Laegeforen; 2002 Jan 20; 122(2):178-82. PubMed ID: 11873574
    [Abstract] [Full Text] [Related]

  • 16. Primary frontal sinus squamous cell carcinoma in three dogs treated with piroxicam combined with carboplatin or toceranib.
    de Vos J, Ramos Vega S, Noorman E, de Vos P.
    Vet Comp Oncol; 2012 Sep 20; 10(3):206-13. PubMed ID: 22236048
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Targeting cancer with small-molecular-weight kinase inhibitors.
    Fabbro D, Cowan-Jacob SW, Möbitz H, Martiny-Baron G.
    Methods Mol Biol; 2012 Sep 20; 795():1-34. PubMed ID: 21960212
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Anticancer therapeutics: "Addictive" targets, multi-targeted drugs, new drug combinations.
    Broxterman HJ, Georgopapadakou NH.
    Drug Resist Updat; 2005 Aug 20; 8(4):183-97. PubMed ID: 16154800
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.